Market Insights Health OTC Pharmaceuticals

Analgesics - Worldwide

Worldwide

The revenue generated in the Analgesics market worldwide amounts to €30.64bn in 2024.
It is projected to experience an annual growth rate of 6.73% (CAGR 2024-2029).
Among all countries, the in the United States generates the highest revenue with €6,716.00m in 2024.
In terms of per person revenues, each individual worldwide generates €3.96 in 2024.
Worldwide, the demand for analgesics in the OTC Pharmaceuticals market continues to grow, with countries like the United States and Japan leading the way in consumption.

Key regions: Brazil, Europe, Germany, Canada, United States

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Analgesics market in Worldwide is experiencing steady growth due to several factors. Customer preferences for pain relief medication, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the development of the Analgesics market.

Customer preferences: Customers worldwide have a growing need for pain relief medication. As the global population ages, the demand for analgesics increases. Additionally, the rising prevalence of chronic diseases and musculoskeletal disorders further drives the demand for pain relief medication. Customers look for effective and affordable analgesics that provide quick relief from pain without significant side effects. They also prefer products that are easily accessible and can be purchased without a prescription.

Trends in the market: One notable trend in the Analgesics market is the increasing popularity of over-the-counter (OTC) analgesics. Customers prefer OTC products as they are convenient to purchase and do not require a doctor's prescription. This trend is particularly prominent in developed countries where consumers have easy access to a wide range of OTC analgesics. On the other hand, emerging markets are witnessing a shift towards self-medication, leading to increased sales of OTC analgesics.Another trend in the market is the growing demand for natural and herbal analgesics. Customers are increasingly seeking alternative options to traditional analgesics, which may have potential side effects. Natural and herbal analgesics are perceived as safer and more sustainable options. This trend is particularly prevalent in regions with a strong focus on wellness and natural remedies.

Local special circumstances: In different countries and regions, there are specific circumstances that impact the Analgesics market. For example, in countries with a high prevalence of opioid addiction, there is a growing concern about the abuse and misuse of prescription analgesics. This has led to stricter regulations and control measures, limiting the availability of certain analgesics. In contrast, countries with a more relaxed regulatory environment may experience a higher demand for prescription analgesics.

Underlying macroeconomic factors: The development of the Analgesics market is also influenced by underlying macroeconomic factors. Economic growth and rising disposable incomes contribute to increased healthcare spending, including the purchase of analgesics. In developing countries, as the middle class expands, there is a greater ability to afford analgesics, driving market growth. Additionally, the healthcare infrastructure and access to healthcare services play a significant role in the development of the Analgesics market. Countries with well-established healthcare systems and easy access to pharmacies tend to have a higher demand for analgesics.In conclusion, the Analgesics market in Worldwide is developing due to customer preferences for pain relief medication, trends in the market such as the popularity of OTC and natural analgesics, local special circumstances such as opioid addiction concerns, and underlying macroeconomic factors including economic growth and healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.